Top Markets
Coin of the day
Alimera Sciences, Inc. Alimera Sciences, Inc.

Alimera Sciences, Inc.

ALIM
주식 순위 #26668
Alimera Sciences, Inc. is a pharmaceutical company focused on developing and... Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.
주가
$5.54
마지막 동기화: 2024-09-18
시가총액
$38.76M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Alimera Sciences, Inc. (ALIM)

카테고리

Alimera Sciences, Inc. (ALIM)의 발행 주식 수
June 2024 기준 발행 주식 수: 54.38M
Alimera Sciences, Inc.의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 54.38M입니다. December 2022 말 기준 회사는 7.00M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Alimera Sciences, Inc. (ALIM)의 발행 주식 수 기록 (2006 ~ 2026)
매년 말 기준 발행 주식 수
연도 발행 주식 수 변화
2026 (TTM) 54.38M 112.75%
2023 25.56M 265.33%
2022 7.00M 6.10%
2021 6.60M 28.86%
2020 5.12M 7.30%
2019 4.77M -18.70%
2018 5.87M 31.37%
2017 4.47M 26.88%
2016 3.52M 18.80%
2015 2.96M 10.03%
2014 2.69M 27.93%
2013 2.11M 0.38%
2012 2.10M 0.29%
2011 2.09M 0.29%
2010 2.09M 1,961.13%
2009 101.16K -6.28%
2008 107.93K 0.00%
2007 107.93K 0.00%
2006 107.93K 0.00%
유사 기업 또는 경쟁사의 발행 주식 수